DLA Piper's Greater China private equity practice has significant experience in the healthcare, software and business services sectors. The team consistently acts for private equity funds, investment firms, family offices and other equity financial investors on buyouts, M&A, cross-border transactions, and joint ventures. It also advises on control and minority investments, venture and growth capital, distressed investments, fund formation, and limited partner investments. In Shanghai, Qiang Li is a widely-respected private equity specialist; and the ‘very responsive and intuitive’ Beijing-based James Chang acts for investors and companies on early-stage and growth capital investments. Luke Gannon heads up the Asia corporate practice from Hong Kong. Former partner Stewart Wang departed the firm in May 2024.
Testimonials
Collated independently by Legal 500 research team.
‘The material advantage is a strong English-speaking team with US expertise, as well as broad familiarity with China laws, which is helpful for foreign/international clients entering the China market.’
‘James Chang is very responsive and intuitive in his guidance.’
Key clients
- Templewater Fund
- Wise Road Capital
Work highlights
- Advising Templewater Fund on its acquisition of Knight Auto Precision Engineering Pte.
- Advising a Middle East sovereign fund on its strategic investment in Viva Biotech Holdings.